Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets.Â
Global Continuous Renal Replacement Therapy Market is valued at approximately USD 1.3 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.1% during the forecast period 2023-2030. Continuous Renal Replacement Therapy (CRRT) is a crucial intervention in managing renal function for critically ill patients facing Acute Kidney Injury (AKI). This method provides a continuous 24-hour dialysis therapy that is particularly beneficial for patients experiencing hemodynamic instability. CRRT involves the gradual removal of solutes from the blood through processes such as hemofiltration, hemodialysis, or a combination of both, and it is administered continuously within an ICU setting, distinguishing it from conventional renal replacement therapies. The market for CRRT has witnessed significant growth due to factors such as the increasing ICU admissions globally, a surge in sepsis-related AKI cases, the growing clinical advantage of CRRT over intermittent blood purification, and the rising prevalence of diabetes and hypertension.
In addition, the rising number of patients in critical care units globally, particularly those experiencing Acute Kidney Injury (AKI) is primarily supporting the market growth. AKI is a prevalent concern in Intensive Care Units (ICUs), and CRRT has proven impactful in managing critically ill patients with this complication. For instance, recent data from the Centers for Disease Control and Prevention (CDC) indicates that around 1.7 million adults in the U.S. develop sepsis, contributing to a high demand for CRRT as a vital component in managing sepsis-associated AKI with its associated morbidity and mortality rates. Also, a National Center for Biotechnology Information (NCBI) article from October 2020 states that between 13% and 18% of hospitalized patients in the United Kingdom suffer from acute renal damage. The therapy is primarily administered to patients with severe conditions such as cancer, diabetes, and cardiac surgery, providing crucial support for 24 hours or longer, depending on the patient’s medical condition. According to the Department of Economic and Social Affairs, in 2019, the world’s population of people aged 65 and up totalled 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. The prevalence of AKI and the growing geriatric population worldwide contribute to the increasing demand for CRRT. The surge in ICU admissions due to age-related health conditions, such as hypertension, cancer, heart disease, diabetes, and stroke, highlights the therapy’s importance in managing acute and chronic health issues. The projected rise in the global aging population further emphasizes the expanding role of CRRT in meeting healthcare needs. These factors collectively drive the continuous expansion of the CRRT Market. Moreover, the development of CRRT from simple renal replacement treatment to multi-organ support therapy, as well as the rising emphasis on the research activities to establish the safety and efficacy profile of CRRT presents various lucrative opportunities over the forecast years. However, the lack of standard treatment guidelines in developing nations and the high complexity of CRRT are hindering market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Continuous Renal Replacement Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high prevalence of Acute Kidney Injury (AKI) among Intensive Care Unit (ICU) patients, robust demand for therapy-related products surpassing other regions, and the presence of well-established healthcare infrastructure. Furthermore, the region benefits from increasing support from regulatory bodies, and the strong presence of product manufacturers contributes to its significant market share. For instance, in April 2022, Baxter International Inc. obtained the 510(k) clearance from the U.S. Food and Drug Administration for its ST Set utilized in this therapy, compatible with PrisMax or Prismaflex control units. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising incidence rates of diabetes, Chronic Kidney Disease (CKD), and hypertension are significantly propelling the market demand across the region. Additionally, increased healthcare expenditure and growing research and development investments contribute to the flourishing healthcare market, which is further supporting the market expansion over the anticipated years.
Major market players included in this report are:
Baxter
B Braun SE
Fresenius Medical Care AG & Co. KGaA
Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
NIPRO Corporation (
Toray Medical Co, Ltd. (Toray Industries, Inc.)
Nikkiso Co., Ltd.
Medtronic PLC
Medica SpA
Medical Components, Inc.
Recent Developments in the Market:
Ø In March 2022, Nipro, a prominent manufacturer of renal products, unveiled the full-scale commercial launch of SURDIAL DX, a cutting-edge hemodialysis system meticulously crafted to deliver optimal dialysis treatment.
Ø In April 2022, Baxter International announced that the ST set used in continuous renal replacement treatment has received FDA (510k) approval. This pre-configured extracorporeal device works in perfect harmony with Prismaflex or PrisMax, using a semipermeable membrane to cleanse blood..
Ø In August 2022, Fresenius Medical Care North America launched the Speedswap system designed for use with the NxStage System One featuring NxView. This innovation aims to minimize downtime, decrease treatment costs, and alleviate nursing burdens associated with this therapy in critical care settings.
Global Continuous Renal Replacement Therapy Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Modality, Age Group, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Dialysates and Replacement Fluids
Disposables
Hemofilters
Bloodline Sets & Tubes
Other Disposables
CRRT Systems
By Modality:
Continuous venovenous hemofiltration (CVVH)
Continuous venovenous hemodiafiltration (CVVHDF)
Continuous venovenous haemodialysis (CVVHD)
Slow continuous ultrafiltration (SCUF)
By Age Group:
Adults
Pediatrics /Neonates
By End User:
Hospital
Ambulatory care
Homecare
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Continuous Renal Replacement Therapy Market, by Region, 2020-2030 (USD Billion)
1.2.2. Continuous Renal Replacement Therapy Market, by Product, 2020-2030 (USD Billion)
1.2.3. Continuous Renal Replacement Therapy Market, by Modality, 2020-2030 (USD Billion)
1.2.4. Continuous Renal Replacement Therapy Market, by Age Group, 2020-2030 (USD Billion)
1.2.5. Continuous Renal Replacement Therapy Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Continuous Renal Replacement Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Continuous Renal Replacement Therapy Market Dynamics
3.1. Continuous Renal Replacement Therapy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Acute Kidney Injury (AKI)
3.1.1.2. Growing clinical advantage of CRRT over intermittent blood purification
3.1.2. Market Challenges
3.1.2.1. Lack of standard treatment guidelines in developing nations
3.1.2.2. High complexity of CRRT
3.1.3. Market Opportunities
3.1.3.1. Development of CRRT from simple renal replacement treatment to multi-organ support therapy
3.1.3.2. Rising emphasis on the research activities to establish safety and efficacy profile of CRRT
Chapter 4. Global Continuous Renal Replacement Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Continuous Renal Replacement Therapy Market, by Product
5.1. Market Snapshot
5.2. Global Continuous Renal Replacement Therapy Market by Product, Performance – Potential Analysis
5.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
5.4.1. Dialysates and Replacement Fluids
5.4.2. Disposables
5.4.3. Hemofilters
5.4.4. Bloodline Sets & Tubes
5.4.5. Other Disposables
5.4.6. CRRT Systems
Chapter 6. Global Continuous Renal Replacement Therapy Market, by Modality
6.1. Market Snapshot
6.2. Global Continuous Renal Replacement Therapy Market by Modality, Performance – Potential Analysis
6.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
6.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
6.4.1. Continuous venovenous hemofiltration (CVVH)
6.4.2. Continuous venovenous hemodiafiltration (CVVHDF)
6.4.3. Continuous venovenous haemodialysis (CVVHD)
6.4.4. Slow continuous ultrafiltration (SCUF)
Chapter 7. Global Continuous Renal Replacement Therapy Market, by Age Group
7.1. Market Snapshot
7.2. Global Continuous Renal Replacement Therapy Market by Age Group, Performance – Potential Analysis
7.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
7.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
7.4.1. Adults
7.4.2. Pediatrics /Neonates
Chapter 8. Continuous Renal Replacement Therapy Market, by End User
8.1. Market Snapshot
8.2. Global Continuous Renal Replacement Therapy Market by End User, Performance – Potential Analysis
8.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
8.4.1. Hospital
8.4.2. Ambulatory care
8.4.3. Homecare
8.4.4. Others
Chapter 9. Global Continuous Renal Replacement Therapy Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Continuous Renal Replacement Therapy Market, Regional Market Snapshot
9.4. North America Continuous Renal Replacement Therapy Market
9.4.1. U.S. Continuous Renal Replacement Therapy Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
9.4.1.3. Age Group breakdown estimates & forecasts, 2020-2030
9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Continuous Renal Replacement Therapy Market
9.5. Europe Continuous Renal Replacement Therapy Market Snapshot
9.5.1. U.K. Continuous Renal Replacement Therapy Market
9.5.2. Germany Continuous Renal Replacement Therapy Market
9.5.3. France Continuous Renal Replacement Therapy Market
9.5.4. Spain Continuous Renal Replacement Therapy Market
9.5.5. Italy Continuous Renal Replacement Therapy Market
9.5.6. Rest of Europe Continuous Renal Replacement Therapy Market
9.6. Asia-Pacific Continuous Renal Replacement Therapy Market Snapshot
9.6.1. China Continuous Renal Replacement Therapy Market
9.6.2. India Continuous Renal Replacement Therapy Market
9.6.3. Japan Continuous Renal Replacement Therapy Market
9.6.4. Australia Continuous Renal Replacement Therapy Market
9.6.5. South Korea Continuous Renal Replacement Therapy Market
9.6.6. Rest of Asia Pacific Continuous Renal Replacement Therapy Market
9.7. Latin America Continuous Renal Replacement Therapy Market Snapshot
9.7.1. Brazil Continuous Renal Replacement Therapy Market
9.7.2. Mexico Continuous Renal Replacement Therapy Market
9.8. Middle East & Africa Continuous Renal Replacement Therapy Market
9.8.1. Saudi Arabia Continuous Renal Replacement Therapy Market
9.8.2. South Africa Continuous Renal Replacement Therapy Market
9.8.3. Rest of Middle East & Africa Continuous Renal Replacement Therapy Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Baxter
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. B Braun SE
10.3.3. Fresenius Medical Care AG & Co. KGaA
10.3.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
10.3.5. NIPRO Corporation
10.3.6. Toray Medical Co, Ltd. (Toray Industries, Inc.)
10.3.7. Nikkiso Co., Ltd.
10.3.8. Medtronic PLC
10.3.9. Medica SpA
10.3.10. Medical Components, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.
Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.
24x7 Chat Support plus
free analyst hours with every purchase
Our 360-degree approach of market study, our research methods leave stones unturned.
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We offer wide range of services including Syndicated Reports, Customized Reports, Competitive Intelligence and others.
